 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 02/02/2026 |
$1.39 |
$1.43 |
$1.36 |
$1.38 |
3.81M | | 02/03/2026 |
$1.39 |
$1.44 |
$1.37 |
$1.41 |
2.36M | | 02/04/2026 |
$1.42 |
$1.42 |
$1.35 |
$1.37 |
3.00M | | 02/05/2026 |
$1.36 |
$1.39 |
$1.35 |
$1.38 |
3.27M | | 02/06/2026 |
$1.36 |
$1.40 |
$1.33 |
$1.39 |
3.39M |
|
|
| Akebia Therapeutics, Inc. is a fully integrated biopharmaceutical company. Co. is focused on developing and commercializing therapeutics. Co.'s portfolio and hypoxia-inducible factor (HIF)-based pipeline includes Auryxia (ferric citrate), Vafseo (vadadustat), AKB-9090 and AKB-10108. Auryxia (ferric citrate) is an orally administered medicine approved and marketed in the U.S. for two indications: the control of serum phosphorus levels in adult patients with dialysis dependent chronic kidney disease (DD-CKD), and the treatment of iron deficiency anemia (IDA), in adult patients with non-dialysis-dependent chronic kidney disease (NDD-CKD). | |
|
Akebia Therapeutics (AKBA) has the following price history information. Looking back at AKBA historical stock prices for the last five trading days, on February 02, 2026, AKBA opened at $1.39, traded as high as $1.43 and as low as $1.36, and closed at $1.38. Trading volume was a total of 3.81M shares. On February 03, 2026, AKBA opened at $1.39, traded as high as $1.44 and as low as $1.37, and closed at $1.41. Trading volume was a total of 2.36M shares. On February 04, 2026, AKBA opened at $1.42, traded as high as $1.42 and as low as $1.35, and closed at $1.37. Trading volume was a total of 3.00M shares. On February 05, 2026, AKBA opened at $1.36, traded as high as $1.39 and as low as $1.35, and closed at $1.38. Trading volume was a total of 3.27M shares. On February 06, 2026, AKBA opened at $1.36, traded as high as $1.40 and as low as $1.33, and closed at $1.39. Trading volume was a total of 3.39M shares.
AKBA Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Akebia Therapeutics shares, starting with a $10,000 purchase of AKBA, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
02/09/2016 |
|
| End date: |
02/06/2026 |
|
| Start price/share: |
$7.14 |
|
| End price/share: |
$1.39 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-80.53% |
|
| Average Annual Total Return: |
-15.10% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$1,945.70 |
|
| Years: |
10.00 |
|
|
|
| Date |
Close |
| 02/02/2026 | $1.38 | | 02/03/2026 | $1.41 | | 02/04/2026 | $1.37 | | 02/05/2026 | $1.38 | | 02/06/2026 | $1.39 |
|
|
Free AKBA Email Alerts:
